Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

被引:22
|
作者
Laura Alberti, Maria [1 ]
Malet Ruiz, Jose Maria [1 ]
Eduardo Fernandez, Martin [1 ]
Fassola, Leandro [1 ]
Caro, Fabian [1 ]
Buendia Roldan, Ivette [2 ]
Paulin, Francisco [1 ]
机构
[1] Hosp Maria Ferrer Buenos Aires, Interstitial Lung Dis Clin, Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermedades Resp INER Ismael Cosio Vil, Buenos Aires, DF, Argentina
来源
PULMONOLOGY | 2020年 / 26卷 / 01期
关键词
Chronic hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Extrinsic allergic alveolitis; Interstitial lung disease; INTERSTITIAL PNEUMONIA; CT FINDINGS; DIAGNOSIS; AZATHIOPRINE;
D O I
10.1016/j.pulmoe.2019.08.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities. Methods: Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline. Results: 146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p = 0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p = 0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p = 0,22). This observation did not change after using Cox proportional hazard analysis. Conclusions: Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations. (C) 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
  • [31] Histopathologic Analysis of Sixteen Autopsy Cases of Chronic Hypersensitivity Pneumonitis and Comparison With Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia
    Akashi, Takumi
    Takemura, Tamiko
    Ando, Noboru
    Eishi, Yoshinobu
    Kitagawa, Masanobu
    Takizawa, Touichirou
    Koike, Morio
    Ohtani, Yoshio
    Miyazaki, Yasunari
    Inase, Naohiko
    Yoshizawa, Yasuyuki
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (03) : 405 - 415
  • [32] A Familial History of Pulmonary Fibrosis in Patients with Chronic Hypersensitivity Pneumonitis
    Okamoto, Tsukasa
    Miyazaki, Yasunari
    Tomita, Makoto
    Tamaoka, Meiyo
    Inase, Naohiko
    RESPIRATION, 2013, 85 (05) : 384 - 390
  • [33] Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study
    Morell, Ferran
    Villar, Ana
    Montero, Maria-Angeles
    Munoz, Xavier
    Colby, Thomas V.
    Pipvath, Sudhakar
    Cruz, Maria-Jesus
    Raghu, Ganesh
    LANCET RESPIRATORY MEDICINE, 2013, 1 (09): : 685 - 694
  • [34] TISSUE LEVELS OF FIBULIN-1 AND PERIOSTIN DO NOT DIFFER BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND CHRONIC HYPERSENSITIVITY PNEUMONITIS
    Bentley, S.
    Tjin, G.
    Jaffarj
    Jones, M.
    Richeldi, L.
    Burgess, J.
    RESPIROLOGY, 2015, 20 : 57 - 57
  • [35] ANALYSIS OF BLOOD CELL COUNTS AS PREDICTORS OF SURVIVAL IN PATIENTS WITH HYPERSENSITIVITY PNEUMONITIS VERSUS IDIOPATHIC PULMONARY FIBROSIS IN A MULTICENTRE RETROSPECTIVE COHORT
    Barratt, S. L.
    Adamali, H.
    Creamer, A.
    Duckworth, A.
    Wollerton, R.
    Fallon, J.
    Gibbons, M. A.
    Gooptu, B.
    Fidan, S.
    Nancarrow, T.
    Pepperell, J.
    Stone, R. A.
    Woodhead, F. A.
    Scotton, C. J.
    THORAX, 2019, 74 : A55 - A55
  • [36] Prospectively Collected Antigen Exposures Do Not Differ Between Patients With Hypersensitivity Pneumonitis And Idiopathic Pulmonary Fibrosis
    Schmidt, S. L.
    Kleaveland, K.
    Han, M. K.
    Toews, G. B.
    Martinez, F. J.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [37] Blood Transcriptomics Differentiates Fibrotic Hypersensitivity Pneumonitis From Idiopathic Pulmonary Fibrosis
    Huang, Y.
    Ma, S.
    Strickland, E.
    Perez, E. R. Fernandez
    Adegunsoye, A. O.
    Kim, J.
    Bonham, C.
    Paul, T.
    Linderholm, A.
    Strek, M. E.
    Oldham, J.
    Martinez, F. J.
    Noth, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [38] Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis
    Selman, M
    Pardo, A
    Barrera, L
    Estrada, A
    Watson, SR
    Wilson, K
    Aziz, N
    Kaminski, N
    Zlotnik, A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (02) : 188 - 198
  • [39] Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
    Kormelink, Tom Groot
    Pardo, Annie
    Knipping, Karen
    Buendia-Roldan, Ivette
    Garcia-de-Alba, Carolina
    Blokhuis, Bart R.
    Selman, Moises
    Redegeld, Frank A.
    PLOS ONE, 2011, 6 (09):
  • [40] Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
    Stijn, Willems
    Stijn, Verleden E.
    Bart, Vanaudenaerde M.
    Marijke, Wynants
    Christophe, Dooms
    Jonas, Yserbyt
    Jana, Somers
    Eric, Verbeken K.
    Geert, Verleden M.
    Wim, Wuyts A.
    ANNALS OF THORACIC MEDICINE, 2013, 8 (01) : 38 - 45